SELENBP1 and neoplasm: Previous studies have only focused on the significant decrease or even disappearance of SELENBP1 expression levels in most cancer tissues like prostate, ovarian, lung, and colorectal cancers, and closely correlated with tumor prognosis, but the mechanisms have not been explored [11–14].